BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• Press Releases

  NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2025

  December 8, 2025

   · 

  2 min read
• Press Releases

  Spyre Therapeutics Announces Grants of Inducement Awards - December 5, 2025

  December 8, 2025

   · 

  1 min read
• Press Releases

  Johnson & Johnson’s INLEXZO™ (gemcitabine intravesical system) delivers 74 percent disease-free survival at one year in BCG-unresponsive, high-risk, papillary-only NMIBC

  December 8, 2025

   · 

  12 min read
• Press Releases

  Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

  December 8, 2025

   · 

  10 min read
• Press Releases

  Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 6, 2025

  December 8, 2025

   · 

  5 min read
• Press Releases

  Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2025

  December 8, 2025

   · 

  5 min read
• Press Releases

  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - December 5, 2025

  December 8, 2025

   · 

  4 min read
• Press Releases

  Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025

  December 8, 2025

   · 

  2 min read
• Press Releases

  Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

  December 8, 2025

   · 

  4 min read
• Press Releases

  Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2025

  December 8, 2025

   · 

  2 min read